22 results
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Epidemiology: • 1-2 cases ... Pathophysiology ... Treatment: • Plasmapheresis ... diagnosis #management #treatment ... #neurology
Extrapulmonary manifestations of COVID-19
 • Neurologic: Headaches, Dizziness, Encephalopathy, Guillain-Barré, Ageusia, Myalgia, Anosmia, Stroke
 • Renal:
of COVID-19 • Neurologic ... Encephalopathy, Guillain-Barré ... Gastrointestinal: Diarrhea, Nausea ... vein thrombosis, Pulmonary ... ischemia, Acute cor pulmonale
Balloon Visualization - Mechanical Ventilation Pressures - PIP, PPlat, PEEP

Peak Inspiratory Pressure (PIP): Dynamic pressure needed
) Inspiratory Pause ... #PPlat #PEEP #CriticalCare ... Diagnosis #Balloon #Pathophysiology ... #Pulmonary
The rationale for aggressive treatment of generalized status epilepticus was described previously here.  In short,
for aggressive treatment ... epilepticus which may cause ... epilepticus may cause ... #Management #Neurology ... #CriticalCare #
Shock Classification Types - Pathophysiology Comparison

Obstructive Shock:
 • Obstructive shock is characterized by a blockage in
Classification Types - Pathophysiology ... in blood flow caused ... Depends on the cause ... Pulmonary embolism ... #Comparison #criticalcare
Massive Hemoptysis - Diagnosis and Management
 • Definitions: 
   - Hemoptysis = bleeding from
has potential to cause ... Diagnosis #Management #treatment ... #workup #pulmonary ... #criticalcare
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... Incidence: 1 to 2 cases ... the underlying pathophysiology ... and cauda equina TREATMENT ... diagnosis #management #neurology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
blood donor • Pathophysiology ... without other cause ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Disease, PRES Pathophysiology ... autoantibodies that will cause ... Puncture, EEG Treatment ... Erythematosus #SLE #CNS #neurology ... diagnosis #management #treatment
Pisa Syndrome (pleurothotonus) on Physical Exam
A tonic flexion of the trunk of the body to one
Caused commonly ... Pathophysiology: ... Treatment: anticholinergics ... PhysicalExam #clinical #neurology